BIOGEN INC's ticker is and the CUSIP is 09062X953. A total of 8 filers reported holding BIOGEN INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $514,020 | +85.6% | 2,000 | +100.0% | 0.01% | 0.0% |
| Q4 2022 | $276,920 | -56.8% | 1,000 | -58.3% | 0.01% | -50.0% |
| Q3 2022 | $641,000 | +176.3% | 2,400 | +118.2% | 0.01% | +50.0% |
| Q1 2022 | $232,000 | -19.4% | 1,100 | -8.3% | 0.01% | 0.0% |
| Q4 2021 | $288,000 | -42.9% | 1,200 | -33.3% | 0.01% | -65.2% |
| Q1 2021 | $504,000 | +71.4% | 1,800 | +63.6% | 0.02% | +15.0% |
| Q2 2020 | $294,000 | – | 1,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 228,400 | $64,635,000 | 0.07% |
| SIMPLEX TRADING, LLC | 193,100 | $67,376,000 | 0.06% |
| HRT FINANCIAL LP | 8,000 | $2,263,000 | 0.01% |
| SG Americas Securities, LLC | 35,100 | $749,000 | 0.00% |
| Allianz Asset Management GmbH | 2,700 | $764,000 | 0.00% |
| JPMORGAN CHASE & CO | 33,600 | $9,508,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,500 | $2,122,000 | 0.00% |